Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
52 other companies have their registered office at the same address; threshold 10.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
NOVOZYMES BELGIUM from Watermaal-Bosvoorde, company number BE0473688810, closed financial year 2025 with a result of € 46,663 after tax. For that financial year NOVOZYMES BELGIUM recorded a gross margin of € 595,118 and equity of € 771,407. Compared with financial year 2024, the result moved from € 40,221 to € 46,663. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 13, 2026.
€ 771,407
▲ 6% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 46,663
▲ 16% vs 2024
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 752,807.
People and assets in 2025
3
Average over the fiscal year, from the social balance sheet.
€ 541,589
▲ 183% vs 2024
€ 180,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 23,887
▲ 25% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 133,006
▲ 192% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,175,164 | € 373,841 | € 217,526 | € 595,118 | ▲ 174% |
| Profit after taxes | € 521,762 | € 72,702 | € 40,221 | € 46,663 | ▲ 16% |
| Equity | € 611,821 | € 684,523 | € 724,743 | € 771,407 | ▲ 6% |
| Total debts | € 1,136,487 | € 76,830 | € 85,730 | € 156,892 | ▲ 83% |
| Retained profit | € 593,221 | € 665,923 | € 706,143 | € 752,807 | ▲ 7% |
| Dividend | € 1,000,000 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 1,748,307 | € 761,353 | € 810,474 | € 928,299 | ▲ 15% |
| Employees (FTE) | 2 | 1 | 0 | 3 |
Key figures of NOVOZYMES BELGIUM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to NOVOZYMES BELGIUM?
What happened at NOVOZYMES BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 46,663 (▲ 16% vs 2024). Source: NBB ↗
- Eva HOLMSGAARD became a director. NBB
- Katrine WILLEMAN became a director. NBB
- Mikkel VILTOFT became a director. NBB
- New establishment in Watermaal-Bosvoorde. KBO
- Start of the company according to the CBE. KBO
In short
From € 521,762 profit in 2022 to € 46,663 profit in 2025.
Paid € 226,001 in corporate taxes since 2022.
Best year ever: 2022, with € 521,762 profit.
On average € 198,400 of value added per employee in 2025.
A new publication or filing at NOVOZYMES BELGIUM? We notify you, reason included.
Follow NOVOZYMES BELGIUMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind NOVOZYMES BELGIUM are Eva HOLMSGAARD, Katrine WILLEMAN and Mikkel VILTOFT.
Directors
According to the 2025 annual accounts
Eva HOLMSGAARD
Director
since 2024
Katrine WILLEMAN
Director
since 2024
Mikkel VILTOFT
Director
since 2010
Establishments
Establishment units
Physical locations of this company
Terhulpsesteenweg 166
1170 Watermaal-Bosvoorde
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 52 companies are registered at this address.
All companies at this address →HLB LEGAL SERVICES
€ 8,327 gross margin · 2025
Glaverbel
Chambre des Urbanistes de Belgique
IM Ultrasonic Belgium
€ -11,018 gross margin · 2025
AGENCE ET PROMOTION IMMOBILIERES
€ 28,264 gross margin · 2025
+47 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0473.688.810
- VAT number
- BE 0473.688.810
- Registered office
- Terhulpsesteenweg 166, 1170 Watermaal-Bosvoorde
- Names & denominations
- NOVOZYMES BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 December 2000
- Peppol
- Not registered
- Activities · NACE
Activiteiten van ingenieurs en aanverwante technische adviseurs, exclusief landmeters-experts
Technische studiën en ingenieursactiviteiten